Standardization of prostate-specific antigen (PSA) assays: Can interchangeability of PSA measurements be improved?

被引：20

作者：

Ishibashi, M ^{[1
]}

机构：

[1] Keio Univ, Sch Med, Dept Lab Med, Shinjuku Ku, Tokyo 1608582, Japan

来源：

CLINICAL CHEMISTRY | 2006年 / 52卷 / 01期

关键词：

D O I：

10.1373/clinchem.2005.061325

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：1 / 2

页数：2

共 13 条

[1]

*CLIN LAB STAND I, 1997, 1LA10A CLSI

[2]

Jung K, 1998, CLIN CHEM, V44, P685

[3]

Kano S, 2001, Rinsho Byori, V49, P967

[4]

KURIYAMA M, 1980, CANCER RES, V40, P4568

[5]

KURIYAMA M, 1992, JPN J CLIN ONCOL, V22, P393

[6] Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer [J].

Mikolajczyk, SD ;

Catalona, WJ ;

Evans, CL ;

Linton, HJ ;

Millar, LS ;

Marker, KM ;

Katir, D ;

Amirkhan, A ;

Rittenhouse, HG .

CLINICAL CHEMISTRY, 2004, 50 (06) :1017-1025

[7] Free prostate-specific antigen in serum is becoming more complex [J].

Mikolajczyk, SD ;

Marks, LS ;

Partin, AW ;

Rittenhouse, HG .

UROLOGY, 2002, 59 (06) :797-802

[8]

Nakamura RM, 2000, PROSTATE CANCER, P203

[9] Reference material for PSA: The IFCC standardization study [J].

Stamey, TA ;

Chen, ZX ;

Prestigiacomo, AF .

CLINICAL BIOCHEMISTRY, 1998, 31 (06) :475-481

[10]

STENMAN UH, 1991, CANCER RES, V51, P222

← 1 2 →